ArticleThe Journal of clinical investigation2008

Ablation of PI3K blocks BCR-ABL leukemogenesis in mice, and a dual PI3K/mTOR inhibitor prevents expansion of human BCR-ABL+ leukemia cells.

Michael G Kharas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.